This document outlines best practices for breaking bad news to patients based on several models, including SPIKES, ABCDE, and BREAK. It discusses preparing for the conversation, building rapport, exploring the patient's understanding, announcing the diagnosis, addressing emotions, and documenting the discussion. The goal is to disclose information compassionately while supporting the patient and addressing their needs.
BBN - Breaking Bad News is difficult task for Junior doctors in India as it was not in the Curriculum unlike Western countries. So this slide will give you the Facts / Methods with Description of one method & Key points.
A talk I gave in Al-Zaem Al-Azhary university on Thursday, 15/5/2014
Outline:
What do we mean by breaking bad news (BBN)?
Which news is bad? really bad? Like really, really bad !
Why should we care about BBN?
Ethical
Professional
Legal
BBN as part of the Communication Cycle/Pathway
Practical approaches to BBN:
SPIKES
ABCDE
BREAKS
The Do Not's in BBN
There is an evident deficiency on how best to break bad news in medicine. This is an essential communication skill that our patients expect of us. It is an essential requisite of Good Medical Practice. This presentation is part of a course held at Al Hammadi Hospital, Suwaidi, Riyadh, KSA on Breaking Bad News. 2017
BBN - Breaking Bad News is difficult task for Junior doctors in India as it was not in the Curriculum unlike Western countries. So this slide will give you the Facts / Methods with Description of one method & Key points.
A talk I gave in Al-Zaem Al-Azhary university on Thursday, 15/5/2014
Outline:
What do we mean by breaking bad news (BBN)?
Which news is bad? really bad? Like really, really bad !
Why should we care about BBN?
Ethical
Professional
Legal
BBN as part of the Communication Cycle/Pathway
Practical approaches to BBN:
SPIKES
ABCDE
BREAKS
The Do Not's in BBN
There is an evident deficiency on how best to break bad news in medicine. This is an essential communication skill that our patients expect of us. It is an essential requisite of Good Medical Practice. This presentation is part of a course held at Al Hammadi Hospital, Suwaidi, Riyadh, KSA on Breaking Bad News. 2017
Last semester's lecture on truth telling and breaking bad news to patients. It was presented by Dr Ghaiath Hussein for Farabi Medical College medical students.
•Don’t make firm predictions
•Do what predictions you do for yourself
•Don’t communicate unless asked
•Don’t be specific
•Don’t be extreme
•Be compassionate and optimistic
Last semester's lecture on truth telling and breaking bad news to patients. It was presented by Dr Ghaiath Hussein for Farabi Medical College medical students.
•Don’t make firm predictions
•Do what predictions you do for yourself
•Don’t communicate unless asked
•Don’t be specific
•Don’t be extreme
•Be compassionate and optimistic
Communication: Empathy and How To Give Bad News -Journal Article and Discussionflasco_org
Providing a course that is relevant, practical and patient-centered that will positively impact the speed in which entry-level oncology specialists integrate into the oncology practice setting.
Medical errors are a growing concern in health care organizations.
No matter how well trained or hard working, healthcare providers make mistakes, just like other professionals.
Some data suggest that medical errors occurs up to 80 times per 100,000 consultations.
Medical errors are the third leading cause of death in the United States.
This presentation mainly explains about the type of patients that are encountered in day to day practice as well as how each of them should be handled to improve the communication between a doctor and the patient.
To the consultation, the patient brings ideas, concerns, expectations, feelings and emotions related to his health problem. These areas are often grouped together and called the “Patent’s Agenda”.
Some of these emotional concerns may be explicit “Open Agenda”, but a large part may never be expressed openly if doctors do not proactively elicit them.
In 1981, Barsky, an American psychiatrist, gave a name to this assortment of hidden concerns; he called it the “Hidden Agenda”.
An important objective of a medical consultation is to understand as much as possible these hidden emotions.
Unless the doctor is able to fathom these, the patient may only be left with therapy that will treat his most obvious symptoms but not resolve the underlying problems.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
2. “I would rather feel compassion than know the
meaning of it”
Thomas Aquinas
“If we do it badly, the patients or family members may
never forgive us; if we do it well, they may never
forget us”
Rob Buckman
3. WHAT IS A BAD NEWS?
Bad news is defined as “Any information which
adversely and seriously affects an individual's view
of his or her future”
Bad news situations can include:
Disease recurrence,
Spread of disease, or failure of treatment to affect
disease progression,
The presence of irreversible side effects, or
Raising the issue of palliative care and resuscitation
5. WHY IS IT DIFFICULT?
It usually means that biomedical measures cannot
help, and thus it undermines the clinician’s familiar
role of the healer.
The clinician is upset.
The patient will be upset too, and can respond
unexpectedly.
The patient may blame the clinician, and indeed
there may be an element of medical mishap to
complicate matters.
6. SOME OTHER BARRIERS
Clinician’s long-standing relationship with the
patient.
The patient is young.
When strong optimism had been expressed for a
successful outcome.
Strong emotions such as anxiety, a burden of
responsibility for the news, and fear of negative
evaluation. This stress creates a reluctance to
deliver bad news, which is named as “MUM” effect.
7. WHO SHOULD BREAK THE
BAD NEWS?
Ideally, bad news should be imparted by the lead
consultant or senior non-consultant hospital doctor,
who is known to the patient or in whom the patient
has trust.
In the exceptional circumstances of sudden death a
senior member of the nursing staff may have to
break bad news. Nurses may play a particular role
in relation to breaking bad news in the inpatient
clinical setting.
8. PATIENT’S RIGHT WITH
REGARD TO BAD NEWS
Patients have a right to:
Accurate and true information.
Receive or not receive bad news.
Decide how much information they want or do not
want.
Decide who should be present during the
consultation, i.e. family.
Members including children and/or significant
others.
Decide who should be informed about their
diagnosis and what information that person(s)
should receive.
9. HOW DO WE KNOW HOW MUCH A
PATIENT WANTS TO KNOW?
Two ways:
BUCKMAN (Canada)
“If this condition turns out to be something serious are you
the type of person who likes to know exactly what is
going on.”
SANSON-FISHER (Australia)
Explicit catagorisation by direct questions in succession
“If you would like to know, I will tell you…..”
What the diagnosis is?
What the treatment will be?
What sort of symptoms you will have?
What examination and test will be necessary?
What can be done for any physical discomfort or pain
you may have?
What the outcome may be?
10. TIME FOR BREAKING THE
BAD NEWS
As early as possible in the diagnostic process the
multidisciplinary team should begin to prepare the
patient for the possibility of bad news.
11. APPROACHES IN BREAKING
BAD NEWS
There are several strategy for braking bad news are
described in various articles.
The important protocols are SPIKES, ABCDE &
BREAK.
12. SPIKES: A SIX STEP
STRATEGY
The protocol (SPIKES) consists of six steps. The goal
is to enable the clinician to fulfill the four most
important objectives of the interview:
Disclosing bad news,
Gathering information from the patient,
Transmitting the medical information providing
support to the patient,
Eliciting the patient's collaboration in developing a
strategy or treatment plan for the future.
13. THE SIX STEPS
Step 1: S—Setting up the interview.
Step 2: P—Assessing the patient's perception.
Step 3: I—Obtaining the patient's invitation.
Step 4: K—Giving knowledge and information to
the patient.
Step 5: E—Addressing the patient's emotions with
empathic responses.
Step 6: S—Strategy & summary.
14. SETTING UP THE INTERVIEW
Arrange for some privacy.
Involve significant others.
Sit down.
Make connection and
establish rapport with the
patient.
Manage time constraints
and interruptions.
15. PERCEPTION OF THE CONDITION
Determine what the patient knows about the
medical condition or what he suspects. (Before you
tell, ASK)
Listen to the patient's level of comprehension.
Accept denial but do not confront at this stage.
Example:
“What have you been told about your condition so far?”
“What is your understanding about why we carried out
the MRI?”
16. INVITATION BY THE PATIENT
Ask patient if s/he wishes to know the details of the
medical condition and/or treatment.
Accept patient's right not to know.
The patient may chose to involve a family member
or friend
Offer to answer questions later if s/he wishes.
17. KNOWLEDGE TO THE PATIENT
Use language intelligible to patient. Example- use
non technical words such as “spread” rather than
“metastasized”.
Consider educational level, socio-cultural
background, current emotional state.
Give information in small chunks.
Check whether the patient understood what you
said.
Respond to the patient's reactions as they occur.
Give any positive aspects first. Example- Cancer
has not spread to lymph nodes, highly responsive
to therapy, treatment available locally etc.
Give facts accurately about treatment options,
prognosis, costs etc.
18. EXPLORE EMOTIONS & SYMPATHIZE
Identify emotions expressed by the patient
(sadness, silence, shock etc.)
Identify cause/ source of emotion
Give the patient time to express his or her feelings,
and then respond in a way that demonstrates you
have recognized connection between first two
points.
19. EXPLORE EMOTIONS &
SYMPATHIZE (CONT.)
Doctor; “I’m sorry to inform you that the scan shows
that you have not responded to the chemotherapy
(pause), unfortunately the cancer has grown
further”
Patient: “I’ve been afraid of this” (cries)
Doctor: (moves his chair closer and offers the
patient a tissue, pauses) “I realise this is news that
you did not want to hear, I am sorry” (allows time for
the patient to respond or allows space for silence).
20. EXPLORE EMOTIONS &
SYMPATHIZE (CONT.)
Empathic statements:
I can see how upsetting this is for you
I can see this news has come as a shock to you
I understand this must be difficult for you
I can see this news has left you feeling angry
Exploratory statements:
You said you were afraid of this news, tell me what frightens
you
Are you able to share with me the reason you feel so angry
Validating responses:
I can understand why that may frighten you
I think your anger is a very normal response to the
circumstances in which you find yourself
21. STRATEGY & SUMMARY
Close the interview.
Ask whether they want to clarify something else.
Explore patients agenda (ICE),
Ideas what may help,
Concerns what is worrying them,
Expectations what are their hope’s for the future
22. ABCDE MODEL
Advance preparation,
Building a therapeutic setting /relationship,
Communicate well,
Deal with patient and family responses,
Encourage and authenticate feelings
23. ADVANCE PREPARATION
What the patient already know/understand already.
Arrange for the presence of a support person and
appropriate family.
Arrange a time and place to be undisturbed.
Prepare yourself emotionally.
Decide on which words and phrases to use—write a
script.
24. BUILD A THERAPEUTIC
ENVIRONMENT
Arrange a private, quiet place without interruptions
Provide adequate seating for all
Sit close enough to touch if appropriate
Reassure about pain, suffering, abandonment.
25. COMMIUNICATE WELL
Be direct - "I am sorry that I have bad news for you.”
Do not use euphemisms, jargon, acronyms.
Use the words – "Cancer," "AIDS," "Death" as
appropriate.
Allow for silence.
Use touch appropriately.
26. DEAL WITH PATIENT & FAMILY
REACTIONS
Assess patient’s reaction: physiologic responses,
cognitive coping strategies, affective responses.
Listen actively, explore, have empathy.
27. ENCOURAGE & VALIDATE
EMOTIONS
Address further needs: What are the patient's
immediate and near term plans?
Make appropriate referrals for more support.
Explore what the news means to the patient.
Express your own feelings.
29. BACKGROUND
An effective therapeutic communication is
dependent on the in-depth knowledge of the
patient's problem. The accessibility of electronic
media has given ample scope for obtaining enough
data on any issue, though authenticity is
questionable.
It is highly desirable to prepare answers for all
questions that can be anticipated from the patient.
The physician must be aware of the patient/relative
who comes after “googling” the problem
30. RAPPORT
Building rapport is fundamental to continuous
professional relationship.
The physician should establish a good rapport with the
patient. He needs to have an unconditional positive
regard, but has to stay away from the temptation of
developing a patronizing attitude.
The ease with which the rapport is being built is the
key to continue conversation.
31. EXPLORING
Whenever attempting to break the bad news, it is easier for
the physician to start from what the patient knows about
his/her illness.
Most of the patients will be aware of the seriousness of the
condition, and some may even know their diagnosis. The
physician is then in a position of confirming bad news
rather than breaking it.
The history, the investigations, the difficulties met in the
process etc need to be explored.
What he/she thinks about the disease and even the
diagnosis itself can be explored, and the potential conflicts
between the patient's beliefs and possible diagnosis can
be identified.
32. ANNOUNCE
A warning shot is desirable, so that the news will
not explode like a bomb.
Euphemisms are welcome, but they should not
create confusion.
The patient has the right to know the diagnosis, at
the same time he has the right to refrain from
knowing it.
Hence, announcement of diagnosis has to be made
after getting consent.
33. KINDLING
People listen to their diagnosis differently.
They may break down in tears. Some may remain
completely silent, some of them try to get up and
pace round the room. Sometimes the response will
be a denial of reality, as it protects the ego from a
potential shatter.
Whatever their reactions may be, the doctor has to
give him time to settle & respond positively.
34. DO’S IN BREAKING BAD NEWS
Allow for silence, tears and other patient reactions.
Allow time.
Be sensitive to the non-verbal language.
Document and liaise with the multidisciplinary team.
Ensure honest and simple language is used.
Ensure privacy and confidentiality and respect both.
Gauge the need for information on an individual basis.
Let the patient talk.
Listen to what the patient says.
35. DON’TS IN BREAKING BAD
NEWS
Assume that you know what is concerning the
patient.
Criticise or make judgements.
Distort the truth
Feel obliged to keep talking all the time.
Give false reassurance.
Overload with information.
Withhold information.
36. DOCUMENTATION OF
BREAKING BAD NEWS
It is important that accurate records are maintained
of the conversation and the information and details
exchanged.
These will assist in the future care of the patient
and enhance communication within the
multidisciplinary team including the patient's
General Practitioner.
This record should be documented in the patient's
notes. The specific words used to describe the
disease should be recorded, for example, tumour,
growth or malignant disease.
37. DOCUMENTATION OF BREAKING
BAD NEWS (CONT.)
The record should min include :
Patients Name/Address:
Hospital Name:
Date and time of interview:
Location: Ward /Outpatients
Names of those present:
Name:
Position/Relationship:
Clinical Diagnosis:
Clinical Options for future management and immediate plan
discussed:
Detail of the words used when breaking the bad news:
Sign of auth physician / social worker / MO
38. CONCLUSION
Breaking bad news is part of the art of medicine.
A bad news is always a bad news, however well it
is said.
But the manner in which it is conveyed can have a
profound effect on both the recipient (the patient)
and the giver (the physician).
If done badly, it will hamper the well being of
patient, impair the quality of life and future contact
with the health care professional will be thwarted.
It is a skill that has to be learnt by the physicians
and other caregivers.